try these out A fantastic read hop over to this website offer lovers painting with big discount , the original source Additional info my review here Check out your url , view publisher site Great paintings of flowers by famous artists With The Best Cheap Price Under $20 painting , Wiht 20% Discount Hottest short blonde wig with dark roots Online Store web link You can find out more , Swiss Replicas . Continue cheap diamond painting how to article .

Blood Journals | Blood Disorders Journals | Blood Reviews | High Impact Articles | Scient Open Access
Journal of Blood Disorders Symptoms and Treatments


Research Article

Treatment of Plasma Replacement Therapy Combined with Intravenous Immunoglobulin and Rituximab or Bortezomib for Acute Antibody Mediated Rejection in ABO-Compatible Kidney Transplant Recipients

Ingrid Magnolia Parra Salinas, Alex Gutierrez-Dalmau, Victoria Paz Gonzalez Rodriguez, Juan Jose Gimeno Lozano, Jose Antonio Gracia Pina, Francisco Javier Paul Ramos, Jose Antonio Garcia-Erce

Correspondence Address :

Ingrid Parra Salinas
Hematology Department Miguel Servet University Hospital
Paseo Isabel La Catolica 1-3
50009 Zaragoza, Spain

Received on: January 25, 2018, Accepted on: February 05, 2018, Published on: February 13, 2018

Citation: Ingrid Magnolia Parra Salinas, Alex Gutierrez-Dalmau, Victoria Paz Gonzalez Rodriguez, et al. (2018). Treatment of Plasma Replacement Therapy Combined With Intravenous Immunoglobulin and Rituximab or Bortezomib For Acute Antibody Mediated Rejection In ABOCompatible Kidney Transplant Recipients

Copyright: 2018 Ingrid Magnolia Parra Salinas, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Abstract

Acute antibody mediated rejection (AAMR) is the principal immunological risk factor for the development of chronic graft dysfunction. The slow reversion of clinical symptoms due to delayed therapeutic effect and the long-term persistence of donor specific antibodies (DSA), are factors that significantly impede the improvement of results in AAMR. This study aims to analyze the response of episodes of AAMR treated with Plasma Replacement Therapy (PRT), and evaluate the safety of the technique.
Materials and Methods: Unicentric retrospective review (prospective database) of 16 patients with ABO compatible renal transplant AAMR, treated with PRT in conjunction with other therapies, over 5 consecutive years. Cases without DSA, absence of histological specific findings and/or low intensity C4d deposits (<2) were designated as suspected. Response (dialysis independence) was evaluated 30 days after terminating PRT.
Results: Median age was 42 years. All received intravenous immunoglobulin (IVIg). Six patients required dialysis. Eleven received rituximab (RTX) which, in seven cases, was in combination with methylprednisolone (MTP). Eleven patients achieved response (3 were suspicious cases). RTX in combination with MTP demonstrated better results (p=0.034). Patients with higher (≥4) Charlson Comorbidity Index demonstrated a certain tendency towards worse results (p=0.077). Out of the 118 sessions performed, 3 cases presented catheter related complications and 5 clinical complications. After a follow-up of 4.7 years, 81.3% of the patients were still alive, and graft survival was 50%.
Conclusions: Combination therapy with PRT, IVIg, RTX and MTP demonstrated greater responses. PRT is a safe therapeutic procedure in our center, probably regarding our prophylactic measures (intravenous calcium gluconate administration at the beginning of the each session and intravenous vitamin K administration at the end of the procedure).

Keywords: Acute antibody mediated rejection, ABO compatible kidney transplantation, Humoral kidney rejection, Plasma exchange, Plasma therapy